TOT BIOPHARM Delays Dispatch of Composite Offer Document
I'm PortAI, I can summarize articles.
WuXi XDC Cayman Inc. and BioDlink International Company Limited have announced a delay in the dispatch of the composite offer document for the proposed acquisition of TOT BIOPHARM International Co. Ltd. This document will include recommendations from the Independent Board Committee and advice from the Independent Financial Adviser. Further details will be provided in the upcoming document.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments